39.500
+1,28%
2026-10-19
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +4.1% | -19.7% | 1 / 3 | -7.8% | -2.56 pp | +4.03 pp | +20.9% | 0.00 | 11.35 | 135 | −7,8% | 47,2 | +4,1% | 11.35 | 11.98 | −5,3% |
| Pts | 0 | 0 | 4 | 0 | 4 | 12 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 39.500 (close price on 2026-10-19)EPS (TTM): 3.481
Financial charts
1.Revenue & growth
VND bn135Q2/26
1.Revenue & growth
VND bn135Q2/26
2.Profit & growth
VND bn47,2Q2/26
3.Profit mix (Penman)
VND bn324Q2/26
4.Margins & cost structure
%49.4%Q2/26
5.Returns & cash cycle
% · days25.1%Q2/26
6.Earnings quality & cash
VND bn328Q2/26
7.Asset structure
VND bn1.333Q2/26
8.Funding & debt health
VND bn · times1.333Q2/26
9.Revenue backlog
VND bn1,71Q2/26
10.Valuation
times · %11,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %629Q2/26
Adjusted EPS growth, latest quarter
4.1%
Average adjusted EPS growth, 3 quarters
-19.7%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26